TabsDetailsBasic DetailsDate Posted: Thursday, March 19, 2020Status: CompleteMedical Product: sitagliptin, sodium-glucose cotransporter-2 (SGLT-2) inhibitorDescription: The objective of this request was to assess the feasibility of using national Patient-Centered Clinical Research Network (PCORnet) data to complement results from queries run against the Sentinel Distributed Database (SDD). PCORnet is comprised of electronic health record data. This request aims to describe the demographic, vital, and clinical characteristics of patients receiving a prescription for sodium-glucose cotransporter-2 (SGLT-2) inhibitors and other select anti-diabetic medications.We used a retrospective study design to identify prevalent users of SGLT-2 inhibitors or sitagliptin within the PCORnet network between March 1, 2013, and June 30, 2018. We included data from 25 PCORnet Data Marts in this report. We distributed this request on October 2, 2019. Read More Deliverables (1)Sentinel Modular Program Report: Characterization of SGLT-2 Inhibitor Users in the Patient-Centered Clinical Research Network (PCORnet)Additional InformationAdditional DetailsFDA Center: CDERTime Period: March 1, 2013 - June 30, 2018Study Type: Modular ProgramAssessment Type: Exploratory AnalysesPopulation / Cohort: All individualsData Sources: Patient-Centered Clinical Research Network (PCORnet)Related Links: Characteristics of Patients Using Anti-Diabetic Agents in the Patient-Centered Clinical Research Network (PCORnet): An Exploratory Query of a Network of Electronic Health Records